A Phase 2 Clinical Trial of Donor Specific Tolerance Induction in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion.

被引:0
|
作者
Leventhal, J. [1 ]
Abecassis, M. [1 ]
Miller, J. [1 ]
Gallon, L. [1 ]
Herzig, R. [2 ]
Tollerud, D. [2 ]
King, B. [2 ]
Ildstad, S. [2 ]
机构
[1] Northwestern Univ, Transplant Ctr, Chicago, IL 60611 USA
[2] U Louisville, Inst Cellular Therapeut, Louisville, KY USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
1
引用
收藏
页码:27 / 27
页数:1
相关论文
共 50 条
  • [1] Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion.
    Leventhal, Joseph R.
    Miller, Joshua
    Gallon, Lorenzo
    Abecassis, Michael M.
    Ravindra, Kadiyala Y. A.
    Reed, Elizabeth
    Herzig, Roger
    Ildstad, Suzanne T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 114 - 114
  • [2] A Phase 2 Clinical Trial of Donor Specific Tolerance Induction in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion
    Leventhal, J.
    Abecassis, M.
    Miller, J.
    Gallon, L.
    Herzig, R.
    Tollerud, D. J.
    King, B.
    Ildstad, S. T.
    TRANSPLANTATION, 2012, 94 (10) : 148 - 148
  • [3] Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion
    Leventhal, J.
    Gallon, L.
    Miller, J.
    Mehta, J.
    Zakarija, A.
    Abecassis, M.
    Tollerud, D.
    Herzig, R.
    Ravindra, K.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 76 - 76
  • [4] Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome
    Leventhal, Joseph
    Abecassis, Michael
    Miller, Joshua
    Gallon, Lorenzo
    Tollerud, David
    Elliott, Mary Jane
    Bozulic, Larry D.
    Houston, Christopher
    Sustento-Reodica, Nedjema
    Ildstad, Suzanne T.
    TRANSPLANTATION, 2013, 95 (01) : 169 - 176
  • [5] Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism
    Leventhal, Joseph R.
    Ildstad, Suzanne T.
    HUMAN IMMUNOLOGY, 2018, 79 (05) : 272 - 276
  • [6] Induction of donor-specific tolerance in living donor kidney transplant recipients through clinical MIC cell infusion - a phase I study (TOL-1)
    Morath, Christian
    Schmitt, Anita
    Kleist, Christian
    Daniel, Volker
    Opelz, Gerhard
    Suesal, Caner
    Kaelble, Florian
    Sommerer, Claudia
    Wang, Lei
    Hueckelhoven, Angela
    Mehrabi, Arianeb
    Merle, Uta
    da Silva, Luiza Pego
    Mueller-Tidow, Carsten
    Zeier, Martin
    Schaier, Matthias
    Schmitt, Michael
    Terness, Peter
    BONE MARROW TRANSPLANTATION, 2018, 53 : 229 - 230
  • [7] Durable Chimerism, Absence of Graft-Versus-Host Disease and the Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Transplants and Therapeutic Cell Transfer
    Leventhal, Joseph
    Abecassis, Michael
    Miller, Joshua
    Gallon, Lorenzo
    Ravindra, Kadiyala
    Tollerud, David J.
    King, Bradley J.
    Herzig, Geoffrey
    Herzig, Roger
    Ildstad, Suzanne T.
    BLOOD, 2011, 118 (21) : 379 - 380
  • [8] HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation
    Senev, Aleksandar
    Tambur, Anat R.
    Kosmoliaptsis, Vasilis
    Copley, Hannah Charlotte
    Garcia-Sanchez, Cynthia
    Usenko, Crystal
    Ildstad, Suzanne T.
    Leventhal, Joseph R.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] A Phase-I Clinical Trial of Donor-Derived MIC Cell Infusion for the Induction of Donor-Specific Hyporesponsiveness after Living Donor Kidney Transplantation (TOL-1 Study).
    Morath, C.
    Schmitt, A.
    Kleist, C.
    Daniel, V.
    Opelz, G.
    Suesal, C.
    Faelble, F.
    Sommerer, C.
    Wang, L.
    Zeier, M.
    Schmitt, M.
    Schaier, M.
    Terness, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 448 - 448
  • [10] A PHASE-I CLINICAL TRIAL OF DONOR-DERIVED MIC CELL INFUSION FOR THE INDUCTION OF DONOR-SPECIFIC HYPORESPONSIVENESS AFTER LIVING DONOR KIDNEY TRANSPLANTATION (TOL-1 STUDY)
    Morath, Christian
    Schmitt, Anita
    Kleist, Christian
    Daniel, Volker
    Opelz, Gerhard
    Suesal, Caner
    Kaelble, Florian
    da Silva, Luiza Pego
    Sommerer, Claudia
    Wang, Lei
    Hueckelhoven, Angela
    Merle, Uta
    Mehrabi, Arianeb
    Muller-Tidow, Carsten
    Zeier, Martin
    Schmitt, Michael
    Schaier, Matthias
    Terness, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 320 - 320